Lumos Pharma, Inc.
LUMODelisted Dec 12, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001126234
Lumos Pharma, Inc. was delisted on Dec 12, 2024; its insiders filed their last Form 4 on Dec 13, 2024; 29 institutions reported holding it in 13F filings for Q3 2024, worth $8.08M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Lumos Pharma, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 37 | 38 | +1 |
| Shares | 2.87M | 2.70M | −164.4K (−5.7%) |
| Value | $27.3M | $18.7M | −$8.53M (−31.3%) |
New holders (6)
Institutions that held Lumos Pharma, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 355,990 | $2.47M | 0.00% |
| Envestnet Asset Management Inc | 10,368 | $72.0K | 0.00% |
| PVG Asset Management Corp | 10,175 | $70.5K | 0.26% |
| American Portfolios Advisors | 1,250 | $8.66K | 0.00% |
| City State Bank | 111 | $1.00K | 0.00% |
| Bank of America Corp | 10 | $0 | 0.00% |
Sold out (5)
Institutions that held Lumos Pharma, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Millennium Management LLC | 15,348 | $146.0K |
| Citadel Advisors LLC | 11,869 | $113.0K |
| Northern Trust Corp | 1,008 | $10.0K |
| Jacobi Capital Management LLC | 5 | $0 |
| Global Retirement Partners, LLC | 11 | $0 |